Skip to main content
Published locations for VARSITY: Better histologic outcomes with vedolizumab than adalimumab in UC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
VARSITY: Better histologic outcomes with vedolizumab than adalimumab in UC
User login
Username
Password
Reset your password
/content/varsity-better-histologic-outcomes-vedolizumab-adalimumab-uc-0
/gihepnews/article/245890/ibd-intestinal-disorders/varsity-better-histologic-outcomes-vedolizumab